Items where authors include "David, K.A."

Article

Katz, D.A., Morris, J.D., Chu, M.P. et al. (17 more authors) (2022) Open-label, phase 2 study of blinatumomab after frontline R-chemotherapy in adults with newly diagnosed, high-risk DLBCL. Leukemia & Lymphoma, 63 (9). pp. 2063-2073. ISSN 1042-8194